SCHEMBL8007300

SCHEMBL8007300

COCCOC(Cc1ccc(OCCN(C)c2nc3ccccc3o2)cc1)C(=O)Cl

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.73
PPARA Q07869 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4865298 0.92 PPARG (0.83) PPARGPPARA
SCHEMBL7826457 0.92 PPARG (0.83) PPARGPPARA
SCHEMBL7825493 0.91 PPARG (0.73) PPARGPPARA
SCHEMBL8007402 0.88 PPARG (0.86) PPARGPPARA
SCHEMBL9267167 0.86 PPARG (0.86) PPARGPPARA
SCHEMBL10211510 0.86 PPARG (0.86) PPARGPPARA
SCHEMBL9270271 0.86 PPARG (0.76) PPARGPPARA
SCHEMBL7815781 0.84 PPARG (1.00) PPARGPPARA
SCHEMBL7825955 0.84 PPARG (0.73) PPARGPPARA
SCHEMBL7816314 0.84 PPARG (0.88) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166049-A Use of an antagonist of PPARα and PPARγ for the treatment of syndrome X SMITHKLINE BEECHAM P.L.C. (GB) 2000-12-26 US disclosed
EP-0879053-A1 USE OF AN ANTAGONIST OF PPAR-ALPHA AND PPAR-GAMMA FOR THE TREATMENT OF SYNDROM X SMITHKLINE BEECHAM PLC (GB) 1998-11-25 EP disclosed
WO-1997025042-A1 USE OF AN AGONIST OF PPAR-ALPHA AND PPAR-GAMMA FOR THE TREATMENT OF SYNDROM X SMITHKLINE BEECHAM P.L.C. (GB) 1997-07-17 WO disclosed
EP-0772605-A1 BENZOXAZOLES AND PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES SMITHKLINE BEECHAM PLC (GB) 1997-05-14 EP disclosed
WO-1996004261-A1 BENZOXAZOLES AND PRYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES SMITHKLINE BEECHAM PLC (GB) 1996-02-15 WO disclosed
WO-1996004260-A1 BENZOXAZOLES AND PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF THE TYPE II DIABETES SMITHKLINE BEECHAM PLC (GB) 1996-02-15 WO disclosed